Fierce Pharma Asia—Vyvanse generics; Lenvima’s trial flop; Adagene’s ADC breakup aliu Thu, 08/31/2023 – 18:41 More: Fierce Pharma Asia—Vyvanse generics; Lenvima's trial flop; Adagene's ADC breakup Source: fierce
read moreAmid Medicare negotiation battle, lawmakers push for answers on insulin prices and patent reform kdunleavy Thu, 08/31/2023 – 14:42 More: Amid Medicare negotiation battle, lawmakers push for answers on insulin prices and patent reform Source: fierce
read moreSanofi shakes up leadership as specialty care head Sibold departs to pursue outside opportunity zbecker Thu, 08/31/2023 – 10:50 More: Sanofi shakes up leadership as specialty care head Sibold departs to pursue outside opportunity Source: fierce
read moreZevra strikes $91M buyout of Acer to catapult itself into commercial rare disease space fkansteiner Thu, 08/31/2023 – 10:37 More: Zevra strikes M buyout of Acer to catapult itself into commercial rare disease space Source: fierce
read moreJohnson & Johnson slashes price of tuberculosis drug Sirturo after relinquishing patent protections kdunleavy Thu, 08/31/2023 – 10:27 More: Johnson & Johnson slashes price of tuberculosis drug Sirturo after relinquishing patent protections Source: fierce
read moreEmergent launches OTC opioid overdose drug, charging $45 so ‘anyone can save a life’ ntaylor Thu, 08/31/2023 – 09:25 More: Emergent launches OTC opioid overdose drug, charging so 'anyone can save a life' Source: fierce
read more© 1994 - 2024 B.M. Pharmaceuticals